NCT07008690 is a clinical trial of MRI in Degenerative Joint Disease, sponsored by University of Minnesota.

Who is sponsoring NCT07008690?

NCT07008690 is sponsored by University of Minnesota.

What drugs are being tested in NCT07008690?

Interventions in NCT07008690: MRI, Magnetic Resonance Imaging.

What condition does NCT07008690 study?

NCT07008690 studies Degenerative Joint Disease, Control Subjects.

Is NCT07008690 still recruiting?

NCT07008690 is currently active, enrolled. Last updated 6 June 2025.

Last reviewed 2025-06-06 · How we verify

NCT07008690

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MRI of the TMJ in Patients With DJD

Active, enrolled Last updated 6 June 2025

What this trial tests

trial testing MRI in Degenerative Joint Disease in 40 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

17 April 2025

Primary endpoint
31 May 2027

28 November 2027

Quick facts

Lead sponsor	University of Minnesota
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	40
Start date	17 April 2025
Primary completion	31 May 2027
Estimated completion	28 November 2027
Sites	1 location across United States

Drugs / interventions tested

MRI — full drug profile →
Magnetic Resonance Imaging

Conditions studied

Degenerative Joint Disease — all drugs for Degenerative Joint Disease →
Control Subjects — all drugs for Control Subjects →

Sponsor

University of Minnesota

Who can join

18 and older, any sex, with Degenerative Joint Disease or Control Subjects. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This observational research is comparative in design, that is assessing the change in qMRI measures in degenerative changes of the TMJ in patients diagnosed with DJD. These patients will be imaged multiple times over the course of 18 months, using clinical 3T MRI scanners located at the Center for Magnetic Resonance Research (CMRR), and their findings will be compared to controls; individuals who are not diagnosed with DJD. No investigational agents or MRI contrast agents will be used.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of MRI

Trials testing the same drug.

NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
NCT07487870 — Radiographic Evaluation of Tumor Biology During Neoadjuvant Radiotherapy for Sarcoma · NA · not yet recruiting
NCT07567053 — Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study · NA · not yet recruiting
NCT07537504 — Language Function Reorganization in Patients With Arteriovenous Malformations · not yet recruiting
NCT07217990 — Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer · Phase 1, PHASE2 · not yet recruiting

Other recruiting trials for Degenerative Joint Disease

Currently open trials in the same condition.

NCT06920459 — Zimmer Biomet Shoulder Arthroplasty PMCF Study · recruiting
NCT05357378 — Safety and Effectiveness of the HIT Reverse HRS · NA · recruiting

Other University of Minnesota trials

Trials by the same sponsor.

NCT02421497 — MRI Technical Development and Applications in Kidney Disease · not yet recruiting
NCT04100109 — Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic · NA · withdrawn
NCT05454306 — Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures · NA · withdrawn
NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
NCT04940533 — Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07008690 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Minnesota
Last refreshed: 6 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07008690.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing